MRITMJ: Magnetic Ressonance Imaging of Temporomandibular Joint

Sponsor
Daniela Ap. Biasotto-Gonzalez (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT02294799
Collaborator
(none)
24
1
2
16
1.5

Study Details

Study Description

Brief Summary

Background: Among the instrumental devices that have been proposed over the years to integrate the clinical evaluation of temporomandibular joint disorders (TMD), imaging techniques are the most studied, showing that magnetic resonance imaging (MRI) is the technique most need to describe the anatomy of the TMJ and to evaluate the correlation of imaging findings with the clinical diagnosis . Despite the amount available studies on the use of MRI for evaluation of TMJ disorders and treatments, there is a lack of studies that evaluate the imaging findings after physical therapy. Purpose: To evaluate the influence of nonspecific mandibular mobilization about the positioning of the articular disc by MRI in individuals with TMD diagnosis of anterior disc displacement with and without reduction according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). Analyze the behavior of pain through the numerical scale of pain assessment (END) at baseline and after each treatment session, the quality of life of individuals with TMD at baseline, immediately, three and six months after the treatment sessions by the World Health Organization Quality of Life Assessment (WHOQOL - BREF), and The Patient's Specific Functional Scale (PSFS) at baseline and after treatment. The treatment will be performed three times a week during four weeks. Metodology: This is a randomized, placebo controlled, blind study designed to assess the effects of techniques nonspecific mandibular mobilization x placebo. Individuals will be randomized and divided into two groups: Group A (intervention) and Group B (placebo). Statistic analysis: The positioning of the articular disc, extracted through the use of MRI, will be considered the primary outcome and, as a secondary outcome will be assessed the quality of life, pain and function after treatment. The adherence of the data to a Gaussian curve will be verified by the Shapiro-Wilk and the data are expressed as mean values and standard deviation. Two-way repeated measures analysis of variance with Bonferroni post hoc test will be used for inter-and intra-group comparisons. The significance level is adjusted p ≤ 0.05.

Condition or Disease Intervention/Treatment Phase
  • Other: Intervention Group
  • Other: Placebo group
N/A

Detailed Description

This is a randomized, placebo-controlled, double-blind study designed to verify the effects of nonspecific mandibular mobilization techniques x placebo

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Magnetic Ressonance Imaging Evaluation of Articular Disc Position in TMD Subjects After Mandibular Mobilization. A Double Blind, Randomized, Placebo-controlled Study
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Intervention Group

TMD diagnosed sujects that will receive the mobilization treatment

Other: Intervention Group
Grade 1, Nonspecific Mandibular Mobilization
Other Names:
  • Mandibular Mobilization
  • Placebo Comparator: Placebo Group

    TMD diagnosed sujects that will receive the placebo treatment

    Other: Placebo group
    Nonspecific Mandibular Movement.
    Other Names:
  • Placebo Mandibular Mobilization
  • Outcome Measures

    Primary Outcome Measures

    1. Articular Disc Positioning (Measured by the Magnetic Ressonance Imaging) [Baseline (day 1) and after 4 weeks of treatment performed 3 times a week.]

      Measured by the Magnetic Ressonance Imaging

    Secondary Outcome Measures

    1. Clinical Symptoms (Measured by END) [Baseline (day 1) and after 4 weeks of treatment performed 3 times a week.]

      Measured by numerical scale of pain assessment (END)

    2. Functionality (Mesuread by "The Patient´s Specific Funcional Scale - HORN, 2012) [Baseline (day 1) and after 4 weeks of treatment performed 3 times a week.]

      Mesuread by "The Patient´s Specific Funcional Scale - HORN, 2012

    3. Quality of life (Whoqol-bref) [Baseline (day 1) and after 4 weeks of treatment (performed 3 times a week), 3 and 6 months follow up]

      Whoqol-bref

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • TMD diagnosed subjects by RDC / TMD confirmed by the MRI findings,

    • with anterior disk displacement with or without reduction,

    • with full dentition (excluding third molars).

    Exclusion Criteria:
    • Subjects diagnosed TMD exclusively muscular;

    • with posterior and / or medial displacement of the disc;

    • showing systemic diseases that affect the joints and / or masticatory muscles;

    • neuromuscular diseases;

    • hypo / condylar hyperplasia;

    • making use of any type of dental prosthesis;

    • are in orthodontic and / or physical therapy;

    • showing neurological or behavioral disorders that preclude the achievement of MRI and/or

    • a history of previous TMJ surgery.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Nove de Julho Sao Paulo São Paulo Brazil 01415000

    Sponsors and Collaborators

    • Daniela Ap. Biasotto-Gonzalez

    Investigators

    • Principal Investigator: Daniela Ap Biasotto-Gonzalez, PHD, University of Nove de Julho

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Daniela Ap. Biasotto-Gonzalez, Phd, University of Nove de Julho
    ClinicalTrials.gov Identifier:
    NCT02294799
    Other Study ID Numbers:
    • YEH1984
    First Posted:
    Nov 19, 2014
    Last Update Posted:
    Mar 7, 2022
    Last Verified:
    Feb 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Daniela Ap. Biasotto-Gonzalez, Phd, University of Nove de Julho
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 7, 2022